Dominik Sievert ^UDM

Dominik Sievert is the Founder and CEO of inveox GmbH, a company dedicated to automating histopathology to make cancer diagnoses faster, safer, and more reliable. Established in 2017, inveox develops systems that digitize, automate, and connect pathology laboratories. The innovative automation system created by inveox for sample preparation in histopathology increases efficiency and safety in pathology laboratories. This not only reduces the risk of operational irregularities and potential misdiagnoses but also significantly improves patient safety, especially in cancer diagnostics. Since its foundation, inveox has received recognition through various awards, including the 2017 "Startup des Jahres," Top 50 Start-ups 2017 from Für Gründer, the "Golden Pretzel" at Bits & Pretzels 2018, and the 2019 EIT Health Award. The company was also listed on the 2018 Forbes list of "most promising startups," participated in the Roche Diagnostics/Plug&Play Digital Health Accelerator 2018, and has been a member of the World Economic Forum since 2019. Under Sievert's leadership, inveox continues to make significant strides in automating and improving histopathology processes, contributing to advancements in cancer diagnosis and overall laboratory efficiency.